Capsa Healthcare Welcomes Jeff Schlossnagle as Chief Commercial Officer to Propel Transformational Growth
Innovative Healthcare Solutions Provider Appoints Seasoned Executive to Lead Strategic Initiatives
COLUMBUS, Ohio, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Capsa Healthcare, a global leader in advanced healthcare workflow solutions, announces the appointment of Jeff Schlossnagle as Chief Commercial Officer (CCO). In this newly created role, Schlossnagle will spearhead sales and go-to-market strategies, driving Capsa's profound transformational endeavors into the future.
With a rich history of experience spanning strategic healthcare communications, market analysis, sales excellence, and operational efficiency, Schlossnagle is poised to chart an ambitious course for Capsa Healthcare. He will oversee Capsa's global Sales, Marketing, Product Management, Sales Support, and Central Filling Technology efforts.
“As healthcare is shifting from patients going to providers to providers going to patients, Capsa is uniquely positioned to advance the delivery of healthcare worldwide. With a presence in over 70 countries, 75% of U.S. health systems, and most of the top retail and institutional pharmacy providers across the world, I am excited about the challenge of building and connecting our innovative solutions through these care environments,” stated Schlossnagle. “Our goal is to improve patient and provider engagements through robotics, automation, connected mobile devices, and cloud infrastructure as we drive innovation and efficiency at the intersection where patients and providers meet across the entire care continuum. Capsa enables this across an array of technologies from the initial direct or virtual provider visit, to the procedure room, to remote patient observation, all the way to central prescription fill and ending at the last mile of delivering patient-specific medications at the pharmacy or to the home. We are a committed team dedicated to collaborating with providers and our innovative partners, ensuring the highest level of care and outcomes for patients globally in any care setting.”
Schlossnagle is a distinguished healthcare executive with an impressive 20-year track record in the medication management sector. Before joining Capsa Healthcare, he held pivotal leadership roles at Omnicell, where he directed sales, marketing, professional services, and customer success. He also orchestrated Omnicell's transformative journey in Specialty Pharmacy Services. Before his tenure at Omnicell, Schlossnagle excelled with Novartis and Abbott.
About Capsa Healthcare:
Capsa Healthcare is a worldwide leader in developing and delivering comprehensive end-to-end workflow solutions. With over 60 years of experience, Capsa Healthcare offers a broad portfolio of mobile workstations, medication carts, medical carts, and pharmacy automation solutions that optimize workflows across the continuum of care. The company's mission is to empower healthcare providers with tools that optimize processes, increase efficiency, elevate safety, and advance engagement, resulting in improved patient outcomes.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
BW Ideol AS – End of Offer Period for the recommended voluntary offer by BW Sirocco Holdings AS, and final level of acceptances of the offer30.11.2023 19:51:43 CET | Press release
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN THE UNITED STATES, CANADA, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES Oslo, 30 November 2023 - Reference is made to the announcement made by BW Sirocco Holdings AS (the "Offeror) on 9 November 2023 regarding a recommended voluntary offer to acquire all the issued and outstanding shares (the "Shares") in BW Ideol AS ("BW Ideol" or the "Company"), not already held by the Initiating Shareholders (as defined in the Offer Document), at an offer price of NOK 12 per Share (the "Offer Price"), to be settled in cash or shares in the Offeror (the "Offer"), as further described in the combined offer document and national prospectus (the "Offer Document"), the announcement on 14 November regarding the publication of the Offer Document and commencement of
Ensurge Micropower ASA - Approval and publication of prospectus; commencement of subscription period in Subsequent Offering30.11.2023 19:32:57 CET | Press release
Reference is made to the stock exchange announcement published on 18 October 2023 by Ensurge Micropower ASA ("Ensurge" or the "Company"), regarding the successful placement of new shares, through an allocation of 122,846,875 new shares in Tranche 1 (the "Tranche 1 Shares") and an allocation of 352,153,125 new shares in Tranche 2 (the "Tranche 2 Shares"), as well as a possible subsequent repair offering raising up to NOK 12.5 million through the offering of up to 125,000,000 shares (the "Offer Shares") on similar terms as the private placement (the "Subsequent Offering"). As stated in the stock exchange announcement on 18 October 2023, the Subsequent Offering and the trading of the Tranche 2 Shares remained subject to approval of a prospectus by the Financial Supervisory Authority of Norway. Further reference is made to the Extraordinary General Meeting held on 10 November 2023 approving the issuance of the Tranche 2 Shares and the Subsequent Offering. The Financial Supervisory Authorit
Acronis Named a Leader in the IDC MarketScape: Worldwide Cyber-Recovery 2023 Vendor Assessment30.11.2023 18:59:51 CET | Press release
BURLINGTON, Mass., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Acronis, the global leader in cyber protection, today announced it had been identified as a Leader in the IDC MarketScape: Worldwide Cyber Recovery 2023 Vendor Assessment (doc #US49787923, November 2023). This is the first IDC MarketScape report about cyber recovery which illustrates the growing importance of both proactive defense and reactive recovery within an organization’s ability to deal with cyberattacks. The IDC MarketScape report cites Acronis’ key offerings, including a single agent that simplifies deployment and enables unique integration capabilities as well as integrated end-point protection. “Acronis was one of the first data protection vendors to identify and target the cyber recovery marketplace nearly five years ago and to rearchitect their solution specifically for cyber recovery,” the IDC MarketScape noted. Additionally, when referencing the company’s fundraising efforts in the past couple of years, the IDC MarketS
Tangem Sets New Standards for Crypto Hardware Wallet Integrity: Introducing Firmware Attestation, Audited by Riscure30.11.2023 18:54:27 CET | Press release
ZUG, Switzerland, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Tangem AG, a leading crypto hardware wallet manufacturer, is thrilled to announce an in-depth software audit of the Tangem Wallet by Riscure, a renowned independent security lab specializing in evaluating the security of embedded software, chips, and devices. This constitutes Tangem's second consecutive security audit success, following a rigorous evaluation by Kudelski Security in 2018, which affirmed the absence of risks, malicious features and backdoors in the hardware wallet. The seamless outcomes of both audits underscore Tangem's unwavering commitment to maintaining the highest standards of security in its products. In this assessment, Riscure examined the source code and architecture of Tangem’s crypto wallet, testing all functionalities and commands accessible through the NFC interface. The primary goal was to identify potential vulnerabilities and logic-related security issues. The security evaluation did not reveal security
Dutch Court Orders Greenpeace Protesters Off NORI Research Vessel, Greenpeace Complies30.11.2023 18:42:09 CET | Press release
The District Court of Amsterdam has ordered Greenpeace International to immediately disembark from the research vessel commissioned by TMC subsidiary Nauru Ocean Resources Inc (NORI) to conduct legally-mandated environmental impact assessments requested by the Legal and Technical Commission of the International Seabed Authority (ISA) Since November 23rd, Greenpeace’s unsafe and unlawful activities have hindered independent scientists in conducting environmental and scientific studies to assess ecosystem function and recovery one year on from NORI’s pilot nodule collection system testNORI commends Greenpeace’s prompt effort to comply with the court order and looks forward to collaborating to ensure the safety of all personnel at sea NEW YORK, Nov. 30, 2023 (GLOBE NEWSWIRE) -- TMC The Metals Company Inc. (“TMC” or “The Metals Company”), an explorer of lower-impact battery metals from seafloor polymetallic nodules, today announced that the District Court of Amsterdam in the Netherlands ha